AI tool boosts imperfect antibiotic candidates, with 85% working in lab tests‎

Researchers at the University of Pennsylvania have developed ApexGO, a novel, AI-powered method for turning promising but imperfect antibiotic candidates into more potent ones. Unlike many existing AI approaches to antibiotic discovery, which screen large databases for molecules that might work, ApexGO starts with a small number of imperfect candidates and improves them step by step, using a predictive algorithm to evaluate each modification and guide the next.